Target intelligence / Profile preview

ATP-dependent lipid A-core flippase (MsbA) (MsbA)

Target
MsbA
Molecular classification
Transporter, ABC transporter, ATP-binding cassette (ABC) superfamily, Lipid flippase
01

Overview

MsbA is an essential ATP-binding cassette (ABC) transporter located in the inner membrane of Gram-negative bacteria. It functions as a lipid flippase, utilizing the energy from ATP hydrolysis to translocate lipid A-core—the hydrophobic anchor of lipopolysaccharide (LPS)—from the inner leaflet to the outer leaflet of the cytoplasmic membrane. This translocation is a critical and rate-limiting step in the biogenesis of the bacterial outer membrane, which serves as a protective barrier against environmental insults and many existing antibiotics. Due to its essentiality for bacterial survival and the lack of a direct human homolog, MsbA is a high-priority target for the development of novel antibacterial agents. Small molecule inhibitors, including quinoline and tetrahydrobenzothiophene derivatives, have been identified that effectively block MsbA function. These inhibitors typically work by trapping the transporter in a specific conformational state, preventing the completion of the catalytic cycle. This leads to the toxic accumulation of LPS precursors in the inner membrane, resulting in membrane defects and eventual bacterial cell death, making it a potent target for treating multidrug-resistant Gram-negative infections.

Other names
Lipid A export ATP-binding/permease protein MsbALipid A flippaseABC transporter MsbALipopolysaccharide transporter MsbA
02

Mechanism of action

Inhibition of lipid A transport by allosterically trapping the transporter in an inward-facing or outward-facing conformation, thereby blocking ATP hydrolysis and the translocation of lipopolysaccharide precursors to the outer membrane.

03

Biological functions

Lipid A transportLipopolysaccharide (LPS) biosynthesisOuter membrane biogenesisMultidrug transportATP hydrolysis
04

Disease associations

InfectionGram-negative bacterial infection
05

Safety considerations

Development of bacterial resistance through binding site mutationsSelectivity over human ABC transporters (e.g., P-glycoprotein)Potential for systemic endotoxin release during rapid bacterial lysisLimited spectrum across different Gram-negative species due to binding site variations
06

Interacting drugs

G907

7 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS) accumulationMembrane stacking phenotypeBacterial loadProcalcitonin (PCT)C-reactive protein (CRP)

Beyond the preview

Go deeper on ATP-dependent lipid A-core flippase (MsbA) (MsbA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent lipid A-core flippase (MsbA) (MsbA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call